LIVE

/BREAKpoint/Bayleef

Variants

MARGINAL · Conviction 4/10

Bayleef

BREAKpoint · #2 · Uncommon

Live NM ask

€26.24

↓ 31.2% 30D

PSA 9

€0.00

USD source

PSA 10

€0.00

USD source

Composite

3.8

Confidence 4/10

3.8

View listing →View price reference →

Buy range€1.38 – €1.81Above market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

3.8

SCORE / 10

Liquidity

3.4

Scarcity

10.0

Era potential

2.8

Friction

3.8

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 11.54%Total population

PSA 10

PSA 9

PSA 8

Total graded

Gem rate 11.54%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

The BREAKpoint Bayleef (#2) currently trades at €26.24 in the raw market. Its 30-day price movement has declined (-31.2%). By market value it ranks #40 of 126 in BREAKpoint — the 70th percentile of the set. Read together, a upper-tier ranking in BREAKpoint alongside softening 30-day momentum frames where Bayleef sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.